Protagenic Therapeutics reports 2023 annual meeting voting results; two Class II directors elected

Protagenic Therapeutics, Inc.new

Robert B. Stein, MD, PhD elected with 974,293 votes for, 56,765 withheld; Jennifer Buell, PhD elected with 963,089 for, 67,969 withheld.
Ratification of MaloneBailey LLP as auditor passed with 2,324,009 for, 9,482 against, 2,451 abstain.
Directors Stein and Buell will serve Class II terms until 2026 annual meeting; board composition updated.
Total shares present at meeting: 2,336,032 out of 4,330,959 entitled to vote.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Protagenic Therapeutics, Inc.new shareholders approved Ratification of MaloneBailey LLP as the independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-12-13 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-12-13

Exact text from the filing

Proposal Two: The stockholders ratified the selection of MaloneBailey LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. For Against Abstain 2,324,009 9,482 2,451

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Protagenic Therapeutics, Inc.new shareholders approved Election of Class II directors at the 2023-12-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-12-13

Exact text from the filing

Proposal One: The stockholders elected each of the following individuals as a Class II director to serve their terms until the Company’s 2026 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified; Name For Against Withheld Broker Non-Votes Robert B. Stein, MD, PhD 974,293 - 56,765 1,304,974 Jennifer Buell, PhD 963,089 - 67,969 1,304,974

View on SEC.gov

550 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Protagenic Therapeutics, Inc.new filing history →

Source: SEC EDGAR

accession 0001493152-23-045033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.